Capital Profile has started the coverage of the Hong Kong-based, Thai-Chinese Lee/Leelalertsuphakun family, which is behind HKEX-listed bio-pharmaceutical business Lee’s Pharmaceutical Holdings, which manufactures and sells medicines in China.
Three siblings Alice Lee Siu Fong, Leelalertsuphakun Wanee and Benjamin Li Xiaoyi sit on the board as chairwoman, managing director and CEO of the company, respectively. Together, they controlled 30.05% of the listco as at the end-2015.
Before the family entered the pharmaceutical industry, it was best known for HKEX-listed Siu-Fung Ceramics Holdings, founded by Siegfried Lee Siu Fung. The company was wound up at the behest of banks in the late 1990s. Siegfried Lee has since re-emerged as chairman and CEO of Frankfurt-listed ceramic sanitaryware maker ROY Ceramics, where his son and daughter are shareholders.
Capital Profile covers 10 members of the Lee/Leelalertsuphakun family and 15 related companies.